PFM Health Sciences, LP PRAX — PRAXIS PRECISION MEDICINES I

Ownership history in PFM Health Sciences, LP  ·  10 quarters on record

AI Ownership Summary

PFM Health Sciences, LP reported PRAXIS PRECISION MEDICINES I (PRAX) in 10 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 1.37% in 2024 Q1. The latest visible filing shows PRAX at 1.04% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this PRAX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was PFM Health Sciences, LP's position in PRAXIS PRECISION MEDICINES I, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

PRAX was reported at 1.04% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.37% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

PRAX stock page PFM Health Sciences, LP fund profile PFM Health Sciences, LP full holdings
How PFM Health Sciences, LP held PRAX — position size vs. price
% of Fund (quarterly)    PRAX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 35,438 +4,275 +13.7% 1.04% $11.4M 2026-05-15 $342.58
2025 Q4 REDUCED 48.6% +9.3% ❌ 31,163 -29,415 -48.6% 0.92% $9.2M 2026-02-17 $328.04
2025 Q3 REDUCED 28.5% +474.7% ❌ 60,578 -24,135 -28.5% 0.25% $3.2M 2025-11-14 $186.42
2025 Q2 REDUCED 47.3% +24.6% ❌ 84,713 -76,153 -47.3% 0.30% $3.6M 2025-08-14 $47.70
2025 Q1 ADDED — — — 160,866 +41,357 +34.6% 0.44% $6.1M 2025-05-15 $37.20
2024 Q4 REDUCED 34.7% -50.8% ✅ 119,509 -63,583 -34.7% 0.57% $9.2M 2025-02-14 $90.77
2024 Q3 REDUCED 59.6% +32.5% ❌ 183,092 -270,054 -59.6% 0.60% $10.5M 2024-11-14 $76.88
2024 Q2 REDUCED 5.1% +39.1% ❌ 453,146 -24,459 -5.1% 0.93% $18.7M 2024-08-14 $51.26
2024 Q1 REDUCED 27.3% -32.5% ✅ 477,605 -178,943 -27.3% 1.37% $29.1M 2024-05-14 $45.90
2023 Q4 INITIATED — — — 656,548 — — 0.88% $14.6M 2024-02-14 $42.29

🏢 Other funds also holding PRAX

As of 2026 Q1 — sorted by position size

72 Investment Holdings, LLC 3Y 42.83% Velan Capital Investment Management LP 3Y 20.34% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 19.3% Cormorant Asset Management, LP 3Y 7Y 14.33% PERCEPTIVE ADVISORS LLC 3Y 7Y 12.83% KVP Capital Advisors, LP 10.32% Vivo Capital, LLC 3Y 7Y 9.11% Lion Point Capital, LP 3Y 7Y 8.57% Ally Bridge Group (NY) LLC 3Y 8.54% B Group, Inc. 7.94%

FAQ About PFM Health Sciences, LP and PRAX

These are the practical questions this page is built to answer before you even open the full history table.

How long has PFM Health Sciences, LP reported owning PRAX?

PFM Health Sciences, LP reported PRAX across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported PRAX position in PFM Health Sciences, LP's portfolio?

The largest reported portfolio weight for PRAX was 1.37% in 2024 Q1.

What is the latest reported PRAX position on this page?

The most recent filing on this page is 2026 Q1, when PFM Health Sciences, LP reported 35,438 shares, equal to 1.04% of portfolio, with an estimated market value of $11.4M.

What does the chart on this PRAX ownership page compare?

The chart compares PFM Health Sciences, LP's quarterly PRAX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did PFM Health Sciences, LP time their PRAX position?

Based on 13F filing dates vs. subsequent PRAX price moves, PFM Health Sciences, LP correctly timed 3 out of 9 reported position changes (33%). The annualised alpha on PRAX relative to SPY over the holding period was +110.3%.

← Back to PFM Health Sciences, LP Holdings